Myelodysplastic Syndromes Panel - Disclosures
Panel Member
|
Yasmin Abaza MD |
Grant/Research Support
|
| AbbVie, Inc. | ALX Oncology | Biomea | BioSight | Curis | Novartis Pharmaceuticals Corporation |
Date Completed
|
06/06/2024 |
Panel Member
|
Aref Al-Kali MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Sarah Anand MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Brian Ball MD, MS |
Grant/Research Support
|
| Syndax Pharmaceuticals |
Date Completed
|
01/27/2025 |
Panel Member
|
John Bennett MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Krist Biakanja III BS |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Marian Birkeland PhD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Nicole Blankenhorn |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Uma Borate MD, MSc |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Andrew Brunner MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Rebecca Bystrom MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Wanxing Chai-Ho MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Sarah DeVincenzo PharmD, BCPS |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Amy DeZern MD, MHS |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Karin Gaensler MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Zhubin Gahvari MD, MS |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Guillermo Garcia-Manero MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Peter Greenberg MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Kristina Gregory MSN, RN |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Elizabeth Griffiths MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Evelyn Handel PharmD, BCOP, BCPS |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Tamanna Haque MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Erin Hesler |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Cindy Hochstetler PhD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Meagan Jacoby MD, PhD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Brian Jonas MD, PhD |
Grant/Research Support
|
| AbbVie, Inc. | Amgen Inc. | Aptose | AROG | Biomea | Bristol Myers Squibb | Celgene Corporation | Forma | Forty Seven, Inc. | Genentech, Inc. | Gilead Sciences, Inc. | GlycoMimetics, Inc. | Hanmi | Immune-Onc | Jazz Pharmaceuticals Inc. | Kymera | Loxo | Pfizer Inc. | Pharmacyclics | Treadwell |
Date Completed
|
07/21/2024 |
Panel Member
|
Sioban Keel MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Rashmi Khanal MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Ashwin Kishtagari MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Emily Kovach BS |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Yazan Madanat MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Lori Maness MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Shannon McCurdy MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Christine McMahon MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Jamie Nguyen PharmD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Olatoyosi Odenike MD, FASCO |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Afaf Osman MD |
Grant/Research Support
|
| Syros Pharmaceuticals |
Date Completed
|
07/15/2024 |
Panel Member
|
Donna Powell DHSc, CMD, RT(T) |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Baleed Vishnu Reddy MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Tim Rinehart |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
David Sallman MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Hamid Sayar MD, MSc |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Abhay Singh MD, MPH |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Richard Stone MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Tiffany Tanaka MD |
Grant/Research Support
|
| Function Oncology |
Date Completed
|
10/11/2024 |
Panel Member
|
Swapna Thota MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Amanda Visnick BSN, RN, OCN |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |